The synthesis and development of poly(ε-caprolactone) conjugated polyoxyethylene sorbitan oleate-based micelles for curcumin drug release: an in vitro study on breast cancer cells

Abstract

The efficacy of PCL–T-M as a drug carrier for the delivery of curcumin against MCF-7 cells and future therapeutic investigations on breast cancer.

Voices in Molecular Pharmaceutics: Meet Dr. Nasim Shadmani Who Utilizes Cell Penetrating Peptides and Nanoparticles for Targeting Hard-to-Reach Areas of the Body Including the Brain

“…Furthermore, developments in drug delivery technology will remove distinctions between drugs and devices. 2 Progressive manufacturing technologies such as 3D printing, robotics, and techniques using living cells for drug delivery will enable pharma companies to develop more complex drugs with greater effectiveness and deliver them in more precise dosages. 3 Also, pharma companies will assign a greater proportion of their research and development budget to biologics drugs.…”

“…Innovative companies, for example, those originating from universities, will new treatment models and formulation approaches for multiple diseases. Furthermore, developments in drug delivery technology will remove distinctions between drugs and devices . Progressive manufacturing technologies such as 3D printing, robotics, and techniques using living cells for drug delivery will enable pharma companies to develop more complex drugs with greater effectiveness and deliver them in more precise dosages .…”